Veeva to Present at Upcoming Investor Conference
Rhea-AI Summary
Veeva (NYSE: VEEV) will present at the Raymond James 2025 TMT and Consumer Conference in New York on Monday, December 8, 2025 at 11:20 a.m. ET. Presenters will be Brian Van Wagener, CFO, and Paul Shawah, EVP Strategy. The presentation will be available via live webcast, with an archived replay posted afterward on Veeva's investor relations site.
Investors can access the live and archived webcast at https://ir.veeva.com.
Positive
- None.
Negative
- None.
News Market Reaction – VEEV
In the Dec 5 session, VEEV declined 0.12%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 04 | Investor conference notice | Neutral | -0.1% | Announcement of Raymond James TMT and Consumer Conference presentation and webcast access. |
| Dec 03 | Product/AI launch | Positive | +0.5% | Launch of Veeva AI Agents for Vault CRM and PromoMats to boost productivity. |
| Nov 24 | Partnership expansion | Positive | -3.4% | Roche expanding use of Vault CRM and Veeva AI across global pharma operations. |
| Nov 20 | Earnings results | Positive | -0.9% | Fiscal 2026 Q3 results with double-digit revenue and income growth plus raised guidance. |
| Nov 04 | Platform adoption | Positive | +0.3% | More than 100 emerging biotechs adopting Veeva Basics across clinical and quality. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news reactions are mixed: product and platform updates sometimes saw modest gains, while strong earnings and a major partnership still coincided with small to moderate declines, suggesting investors do not always reward positive fundamentals immediately.
Over the last few months, Veeva reported strong fiscal 2026 Q3 results on Nov 20 with solid revenue and profit growth, yet the stock fell 0.92% the next day. An expanded Roche partnership on Nov 24 and the launch of Veeva AI Agents on Dec 3 highlighted its AI and CRM strategy, with reactions of -3.41% and +0.5%, respectively. The current Dec 4 conference announcement, tied to a small -0.12% move, fits a pattern where conference notices usually prompt only modest price changes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Raymond James 2025 TMT and Consumer Conference,
New York, NY . Brian Van Wagener, CFO, and Paul Shawah, EVP Strategy, will present on Monday, December 8, 2025, at 11:20 a.m. Eastern Time.
The above presentation will be webcast. Links to the live and archived webcast will be available on Veeva's investor relations website at https://ir.veeva.com.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts.
Investor Relations Contact: | ||
Gunnar Hansen Veeva Systems Inc. 267-460-5839 Media Contact: Maria Scurry |
View original content:https://www.prnewswire.com/news-releases/veeva-to-present-at-upcoming-investor-conference-302633469.html
SOURCE Veeva Systems